LIFE SCIENCE INSTRUMENTATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Life Science Instrumentation Market, By Technology (Polymerase Chain Reaction, Next Generation Sequencing, Immunoassay, Flow Cytometry, Spectroscopy, Electrophoresis, Chromatography, Centrifuges, and Other Technologies), By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Academia and Research Institutes), By Application (Clinical & Diagnostic, Research, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

On April 2024, LICORbio, formerly known as LI-COR Biotechnology, launched two new Odyssey F biomolecular imaging systems. These advanced models promise faster scans, enhanced value, expanded assay support, and maintain the exceptional dynamic range that researchers expect from LICORbio. According to Mike Furtaw, Director of R&D at LICORbio, the Odyssey F represents a significant advancement in their optical imaging technology, offering industry-leading capabilities for speed, versatility in applications, and multiplexing capabilities across both visible and near-infrared spectra.
In June 2022, Agilent Technologies introduced new quadrupole mass spectrometers for both liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS), designed to enhance built-in instrument intelligence and provide advanced diagnostic capabilities aimed at maximizing system uptime for customers.
In March 2022, Shimadzu, leading-edge science and technology company Europe launched the IRXross Fourier-transform infrared (FTIR) spectrophotometer. This new mid-level FTIR device offers outstanding performance metrics such as a high signal-to-noise ratio, excellent resolution, rapid measurement capabilities, and user-friendly operation.